Equities

Evixar Inc

4257:TYO

Evixar Inc

Actions
  • Price (JPY)1,200.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 22 2021.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Evixar Inc's revenues fell -14.29% from 176.70m to 151.46m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 105.67m to a larger loss of 127.79m.
Gross margin57.04%
Net profit margin-63.31%
Operating margin-58.98%
Return on assets-135.15%
Return on equity--
Return on investment-576.47%
More ▼

Cash flow in JPYView more

In 2023, Evixar Inc increased its cash reserves by 136.28%, or 49.51m. Cash Flow from Financing totalled 157.71m or 104.13% of revenues. In addition the company used 106.89m for operations while cash used for investing totalled 1.32m.
Cash flow per share-42.07
Price/Cash flow per share--
Book value per share-43.20
Tangible book value per share-43.20
More ▼

Balance sheet in JPYView more

Evixar Inc appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load outweighs its assets while day-to-day operations are losing money. One plus is that there are enough liquid assets to satisfy current obligations, however, this situation is unsustainable over the long run. Evixar Inc has considerable financial risk.
Current ratio0.8601
Quick ratio0.8513
Total debt/total equity--
Total debt/total capital3.33
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.